Literature DB >> 24305766

Fear of progression.

Peter Herschbach1, Andreas Dinkel.   

Abstract

Fear of progression (or fear of recurrence) is an appropriate, rational response to the real threat of cancer and cancer treatments. However, elevated levels of fear of progression can become dysfunctional, affecting well-being, quality of life, and social functioning. Research has shown that fear of progression is one of the most frequent distress symptoms of patients with cancer and with other chronic diseases. As a clear consensus concerning clinically relevant states of fear of progression is currently lacking, it is difficult to provide a valid estimate of the rate of cancer patients who clearly suffer from fear of progression. However, recent systematic reviews suggest that probably 50 % of cancer patients experience moderate to severe fear of progression. Furthermore, many patients express unmet needs in dealing with the fear of cancer spreading. These results underline the necessity to provide effective psychological treatments for clinical levels of fear of progression. A few psychosocial interventions for treating fear of progression have been developed so far. Our own, targeted intervention study showed that dysfunctional fear of progression can be effectively treated with a brief group therapy.

Entities:  

Mesh:

Year:  2014        PMID: 24305766     DOI: 10.1007/978-3-642-40187-9_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  13 in total

1.  From normal response to clinical problem: definition and clinical features of fear of cancer recurrence.

Authors:  Sophie Lebel; Gozde Ozakinci; Gerald Humphris; Brittany Mutsaers; Belinda Thewes; Judith Prins; Andreas Dinkel; Phyllis Butow
Journal:  Support Care Cancer       Date:  2016-05-12       Impact factor: 3.603

2.  The unmet supportive care needs-what advanced lung cancer patients' caregivers need and related factors.

Authors:  Shu-Ching Chen; Shiuan-Chen Chiou; Chong-Jen Yu; Yun-Hsiang Lee; Wei-Yu Liao; Pei-Yin Hsieh; Sin-Yuan Jhang; Yeur-Hur Lai
Journal:  Support Care Cancer       Date:  2016-02-13       Impact factor: 3.603

3.  [Psychotherapeutic and psychosocial interventions in cancer].

Authors:  P Herschbach
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

4.  Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers.

Authors:  Sharon L Manne; Shannon Myers-Virtue; David Kissane; Melissa L Ozga; Deborah A Kashy; Stephen C Rubin; Norman G Rosenblum; Carolyn J Heckman
Journal:  Psychooncology       Date:  2016-08-09       Impact factor: 3.894

5.  Fear of Cancer Recurrence and Death Anxiety: Unaddressed Concerns for Adult Neuro-oncology Patients.

Authors:  Ashlee R Loughan; Autumn Lanoye; Farah J Aslanzadeh; Audrey Ann Lois Villanueva; Rachel Boutte; Mariya Husain; Sarah Braun
Journal:  J Clin Psychol Med Settings       Date:  2021-03

Review 6.  Evidence of psychological and biological effects of structured Mindfulness-Based Interventions for cancer patients and survivors: A meta-review.

Authors:  Juliana Pedro; Sara Monteiro-Reis; Carina Carvalho-Maia; Rui Henrique; Carmen Jerónimo; Eunice R Silva
Journal:  Psychooncology       Date:  2021-07-28       Impact factor: 3.955

7.  The fear of cancer recurrence and progression in patients with pancreatic cancer.

Authors:  Esther N Pijnappel; Willemieke P M Dijksterhuis; Mirjam A G Sprangers; Simone Augustinus; Judith de Vos-Geelen; Ignace H J T de Hingh; Izaak Q Molenaar; Olivier R Busch; Marc G Besselink; Johanna W Wilmink; Hanneke W M van Laarhoven
Journal:  Support Care Cancer       Date:  2022-02-15       Impact factor: 3.359

8.  New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.

Authors:  Jochen Hefner; Sara Berberich; Elena Lanvers; Maria Sanning; Ann-Kathrin Steimer; Volker Kunzmann
Journal:  Patient Prefer Adherence       Date:  2017-11-14       Impact factor: 2.711

9.  Fear of disease progression in carriers of the m.3243A > G mutation.

Authors:  José A E Custers; Paul de Laat; Saskia Koene; Jan Smeitink; Mirian C H Janssen; Christianne Verhaak
Journal:  Orphanet J Rare Dis       Date:  2018-11-13       Impact factor: 4.123

Review 10.  Treatment delays in oncology patients during COVID-19 pandemic: A perspective.

Authors:  Divyesh Kumar; Treshita Dey
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.